Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Br J Radiol. 2012 Sep;85(1017):1211-21. doi: 10.1259/bjr/64534573.

    Utility of positron emission tomography/CT in the evaluation of small bowel pathology.

    Source

    Department of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital, Boston, MA, USA. cgcronin@partners.org

    Abstract

    We describe the management principles and different roles of positron emission tomography (PET)/CT in the evaluation of patients with small bowel tumours (adenocarcinoma, gastrointestinal stromal tumour, lymphoma, metastases) from initial staging, monitoring response to treatment, to detection of recurrent disease. We also discuss the various non-malignant aetiologies of small bowel fludeoxyglucose (FDG) PET uptake, and other pitfalls in FDG PET/CT interpretation. Awareness of the imaging appearances of small bowel tumours, patterns of disease spread and potential PET/CT interpretation pitfalls are of paramount importance to optimise diagnostic accuracy.

    PMID:
    22919004
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3487051
    [Available on 2013/9/1]

      Supplemental Content

      Icon for HighWire

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk